Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Helen W. Sullivan, Amie C. O’Donoghue, Douglas J. Rupert, Jessica Fitts Willoughby & Kathryn J. Aikin. (2017) Placement and Format of Risk Information on Direct-to-Consumer Prescription Drug Websites. Journal of Health Communication 22:2, pages 171-181.
Read now
Read now
Anat Klin & Yovav Eshet. (2017) Reading between the lines: questionable medical and journalistic ethics in Israeli newspaper coverage of medications. Israel Affairs 23:1, pages 87-107.
Read now
Read now
Ilwoo Ju & Jin Seong Park. (2015) Communication Strategies in Direct-to-Consumer Prescription Drug Advertising (DTCA): Application of the Six Segment Message Strategy Wheel. Journal of Health Communication 20:5, pages 546-554.
Read now
Read now
Jisu Huh & Wonsun Shin. (2014) Trust in Prescription Drug Brand Websites: Website Trust Cues, Attitude Toward the Website, and Behavioral Intentions. Journal of Health Communication 19:2, pages 170-191.
Read now
Read now
Hannah Kang & Soontae An. (2013) How Direct-to-Consumer Drug Websites Convey Disease Information: Analysis of Stigma-Reducing Components. Journal of Health Communication 18:12, pages 1477-1491.
Read now
Read now
Alexander Lyon & JulienC. Mirivel. (2011) Reconstructing Merck's Practical Theory of Communication: The Ethics of Pharmaceutical Sales Representative–Physician Encounters. Communication Monographs 78:1, pages 53-72.
Read now
Read now
Penny Mansell & John Read. (2009) Posttraumatic Stress Disorder, Drug Companies, and the Internet. Journal of Trauma & Dissociation 10:1, pages 9-23.
Read now
Read now
Articles from other publishers (23)
Brian J. Taylor & S. Anne Moorhead. 2020. Communicating about Risks and Safe Use of Medicines. Communicating about Risks and Safe Use of Medicines
219
265
.
Carmen Domínguez-Falcón, Domingo Verano-Tacoronte & Marta Suárez-Fuentes. (2018) Exploring the customer orientation of Spanish pharmacy websites. International Journal of Pharmaceutical and Healthcare Marketing 12:4, pages 447-462.
Crossref
Crossref
Ilwoo Ju. (2017) The effects of advertising skepticism in consumer prescription drug advertising. International Journal of Pharmaceutical and Healthcare Marketing 11:4, pages 395-411.
Crossref
Crossref
Jacqueline B. Amoozegar, Douglas J. Rupert, Helen W. Sullivan & Amie C. O’Donoghue. (2017) Consumer confusion between prescription drug precautions and side effects. Patient Education and Counseling 100:6, pages 1111-1119.
Crossref
Crossref
Ilwoo Ju. (2017) Thinking about fair balance: how prescription drug advertising disclosure prominence works?. International Journal of Pharmaceutical and Healthcare Marketing 11:1, pages 2-15.
Crossref
Crossref
Tim K. Mackey. (2016) Digital Direct-to-Consumer Advertising: A Perfect Storm of Rapid Evolution and Stagnant Regulation Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters". International Journal of Health Policy and Management 5:4, pages 271-274.
Crossref
Crossref
Brian G. Southwell & Douglas J. Rupert. (2016) Future Challenges and Opportunities in Online Prescription Drug Promotion Research Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters". International Journal of Health Policy and Management 5:3, pages 211-213.
Crossref
Crossref
Thomas WetterThomas Wetter. 2016. Consumer Health Informatics. Consumer Health Informatics
61
81
.
Jisu Huh & Wonsun Shin. (2015) Consumer responses to pharmaceutical-company-sponsored disease information websites and DTC branded websites. International Journal of Pharmaceutical and Healthcare Marketing 9:4, pages 306-329.
Crossref
Crossref
Hisashi Urushihara, Gen Kobashi, Hideaki Masuda, Setsuko Taneichi, Michiko Yamamoto, Takeo Nakayama, Koji Kawakami, Tsutomu Matsuda, Kaori Ohta & Hiroki Sugimori. (2014) Pharmaceutical company perspectives on current safety risk communications in Japan. SpringerPlus 3:1.
Crossref
Crossref
Oliver Rudolf Herber, Verena Gies, David Schwappach, Petra Thürmann & Stefan Wilm. (2014) Patient information leaflets: informing or frightening? A focus group study exploring patients’ emotional reactions and subsequent behavior towards package leaflets of commonly prescribed medications in family practices. BMC Family Practice 15:1.
Crossref
Crossref
Scott Monteith, Tasha Glenn & Michael Bauer. (2013) Searching the internet for health information about bipolar disorder: some cautionary issues. International Journal of Bipolar Disorders 1:1.
Crossref
Crossref
Deborah H. Charbonneau. (2013) An analysis of benefits and risk information on pharmaceutical web sites for the treatment of menopause. Health Information & Libraries Journal 30:3, pages 212-219.
Crossref
Crossref
Joel J Davis. (2012) Content analysis of efficacy descriptions on branded pharmaceutical websites. Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing 12:4, pages 211-220.
Crossref
Crossref
Brian Edwards & Sweta Chakraborty. (2012) Risk Communication and the Pharmaceutical Industry. Drug Safety 35:11, pages 1027-1040.
Crossref
Crossref
Barbara Mintzes. (2012) Advertising of Prescription-Only Medicines to the Public: Does Evidence of Benefit Counterbalance Harm?. Annual Review of Public Health 33:1, pages 259-277.
Crossref
Crossref
Shannon Hughes & David Cohen. (2011) Can Online Consumers Contribute to Drug Knowledge? A Mixed-Methods Comparison of Consumer-Generated and Professionally Controlled Psychotropic Medication Information on the Internet. Journal of Medical Internet Research 13:3, pages e53.
Crossref
Crossref
Michael R Law, Barbara Mintzes & Steven G Morgan. (2011) The Sources and Popularity of Online Drug Information: An Analysis of Top Search Engine Results and Web Page Views. Annals of Pharmacotherapy 45:3, pages 350-356.
Crossref
Crossref
Patricia Wright. (2010) Health Information via the internet. Health Information via the internet.
Joel J Davis. (2009) The effect of placement and modality on the recall of information from pharmaceutical web sites. Journal of Medical Marketing 10:2, pages 99-114.
Crossref
Crossref
Dominick L. FroschDavid GrandeDerjung M. TarnRichard L. Kravitz. (2010) A Decade of Controversy: Balancing Policy With Evidence in the Regulation of Prescription Drug Advertising. American Journal of Public Health 100:1, pages 24-32.
Crossref
Crossref
Joel J Davis & Aimee Meader. (2009) Beyond content analysis: Assessing fair balance in DTC pharmaceutical advertising. Journal of Medical Marketing 9:1, pages 57-66.
Crossref
Crossref
Giampaolo Velo & Ugo Moretti. (2008) Direct‐to‐consumer information in Europe: the blurred margin between promotion and information. British Journal of Clinical Pharmacology 66:5, pages 626-628.
Crossref
Crossref